Platelet glass bead retention predicts bleeding after cardiac surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 15, Issue 1, 2001, Pages 49-54

  Ereth, Mark H ^a   Nuttall, Gregory A ^a   Ericson, Daniel G ^a   Cooney IV, William P ^a   Fisher, Brent R ^a   Oliver, William C ^a   Schaff, Hartzell V ^a   Fass, David N ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Coagulation; Laboratory analysis; Monitoring; Platelet function; Platelet retention; Transfusion

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; ELECTIVE SURGERY; FEMALE; HUMAN; MALE; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

EID: 0035114440     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2001.20274     Document Type: Article

References (38)

1. Platelet activation and aggregation during cardiopulmonary bypass
2. Platelet function during cardiac operation: Comparison of membrane and bubble oxygenators
3. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective α-granule release
4. Hemostatic defects associated with cardiac surgery, prosthetic devices, and other extracorporeal circuits
5. Coronary artery bypass grafting: The Society of Thoracic Surgeons national database experience
6. The variability of transfusion practice in coronary artery bypass surgery
7. Transfusion medicine: Second of two parts - Blood conservation
8. Collection and transfusion of blood and blood components in the United States, 1994
9. Economic impact of inappropriate blood transfusion in coronary artery bypass graft surgery
10. Coagulation tests predict bleeding after cardiopulmonary bypass
11. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss
12. Alterations of hemostasis associated with cardiopulmonary bypass
13. Hemostasis changes during cardiopulmonary bypass surgery
14. Postoperative bleeding in cardiovascular surgery: Does heparin rebound really exist?
15. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients
16. Complement and the damaging effects of cardiopulmonary bypass
17. Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass
18. Blood platelets in cardiopulmonary bypass operations: Recovery occurs after initial stimulation, rather than continual activation
19. Loss of platelet alpha2-adrenergic receptors during simulated extracorporeal circulation: Prevention with prostaglandin E1
20. Platelet function in cardiopulmonary bypass and artificial organs
21. Acute and chronic changes in platelet volume and count after cardiopulmonary bypass-induced thrombocytopenia in man
22. Relationship of platelet aggregation to bleeding after cardiopulmonary bypass
23. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients
24. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction: A scanning electron microscope study
25. Aprotinin improves hemostasis after cardiopulmonary bypass better than single-donor platelet concentrate
26. Bedside coagulation monitoring
27. Molecular markers of hemostatic activation: Implications in the diagnosis of thrombosis, vascular, and cardiovascular disorders
28. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery
29. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery
30. Determination of normal versus abnormal activated partial thromboplastin time and prothrombin time after cardiopulmonary bypass
31. Platelet adhesiveness in von Willebrand's disease
32. Measurement of platelet adhesiveness: A simple in vitro technique demonstrating an abnormality in von Willebrand's disease
33. Coagulation fibrinolysis and bleeding after open-heart surgery
34. Does the platelet activated clotting test (HemoSTATUS) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass?
35. Reductions in platelet force development by cardiopulmonary bypass are associated with hemorrhage
36. Does platelet size correlate with function in patients undergoing cardiac surgery?